Mehdi Brahmi, MD, PhD

Dr
Centre Leon Berard
Lyon, Rhone-Alpes, France

MD, Medical oncologist, Senior physician
Clinical Expertise: Sarcomas of Soft Tissue and Bone
Centre Léon Bérard, Comprehensive Cancer Centre of Lyon
Member of the FSG (French Sarcoma Group), the ESMO (European Society for Medical Oncology) and the EORTC (European Organisation for Research and Treatment of Cancer) STBSG
PhD, Molecular Biology
Cancer Reasearch Center of Lyon, Université Claude Bernard Lyon 1
Team « Genetics, Epigenetics and Biology of Sarcomas »

Disclosure information not submitted.

Presentation(s):

• Paper 17 - INTEREST OF A SEQUENTIAL MULTIMODAL APPROACH FOR THE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH MULTIMETASTATIC EWING SARCOMA: RESULTS OF THE FRENCH PROSPECTIVE COMBINAIR3 PHASE II TRIAL

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 21 - PHASE 1 RESULTS OF THE WEE1 INHIBITOR, AZENOSERTIB, IN COMBINATION WITH GEMCITABINE IN ADULT AND PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 44 - COMBINATION OF MDM2 AND CDK4/6 INHIIBITOR IN PATIENTS WITH ADVANCED WELL AND DE-DIFFERENCIATED LIPOSARCOMA AND OTHERS CANCERS: COHORT ANALYSIS FROM THE MEGAMOST PHASE II BASKET STUDY

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST